Castro Valley, CA, United States of America

Gary Conard Visor

USPTO Granted Patents = 12 (Patent Applications = 5)

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 182(Granted Patents)

Company Filing History:

Hoffmann-la Roche Inc.

patents

2 out of 441

Daiichi Sankyo Company, Limited

patents

4. 1 out of 118

Osi Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11103505 - Formulations of a compound modulating kinases (2021-08-31),

2. 10961240 - Formulations of a compound modulating kinases (2021-03-30),

3. 10941142 - Formulations of a compound modulating kinases (2021-03-09),

4. 10584122 - Solid forms of a compound modulating kinases (2020-03-10),

5. 10435404 - Formulations of a compound modulating kinases (2019-10-08),

6. 10316032 - Solid forms of a compound for modulating kinases (2019-06-11),

7. 10189833 - Solid forms of a compound modulating kinases (2019-01-29),

8. 9802932 - Solid forms of a compound modulating kinases (2017-10-31),

9. 9663517 - Compositions and uses thereof (2017-05-30),

10. 9447089 - Compositions and uses thereof (2016-09-20),

11. 8865735 - Solid forms of a pharmaceutically active substance (2014-10-21),

12. 8557814 - mTOR inhibitor salt forms (2013-10-15),

Title: Gary Conard Visor: Innovator in Kinase Modulation

Introduction

Gary Conard Visor is a prominent inventor based in Castro Valley, CA (US), known for his significant contributions to the field of kinase modulation. With a total of 12 patents to his name, Visor has made remarkable advancements in pharmaceutical formulations that enhance the efficacy of therapeutic compounds.

Latest Patents

Among his latest patents, Visor has developed formulations of a compound modulating kinases. These patents include solid dispersions of Compound I, which are designed to be substantially amorphous. He has also outlined methods for manufacturing these solid dispersions and their applications. Another notable patent involves compositions comprising Compound I and a solubilizing agent, along with methods for their production and use.

Career Highlights

Visor has had a distinguished career, working with leading companies in the pharmaceutical industry. He has been associated with Plexxikon Inc. and Hoffmann-La Roche Inc., where he has contributed to innovative research and development projects.

Collaborations

Throughout his career, Visor has collaborated with esteemed colleagues, including Prabha N Ibrahim and Hamid Rezaei. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Gary Conard Visor's work in kinase modulation exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations continue to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.